Orano Med Lays Foundations for New Manufacturing Site for the Production of Lead-212 Radioligand The

ONNAING, France--(BUSINESS WIRE)--Regulatory News:Orano Med (a subsidiary of the Orano Group), a pioneer in the development of targeted alpha therapies for oncology, today laid the foundation stone for its ATLab (Alpha Therapy Laboratory) in Onnaing (France, 59). This will be Europe's first industrial-scale pharmace...

Related Keywords

United States ,Onnaing ,Nord Pas De Calais ,France ,French ,Aurore Colson ,Julien Dodet ,Laurent Degallaix ,Guillaume Dureau ,Guillaume Quenet ,Atlab Valenciennes ,Xavier Jouanin ,Nuclear Medecine ,Nuclear Medicine For The Orano Group ,Atlab Alpha Therapy Laboratory In Onnaing France ,Orano Group Senior Executive Vice ,French Agency For Ecological Transition ,French National Research Agency ,Morano Group ,Health Innovation Agency ,French Health Innovation Agency ,Regulatory News ,Alpha Therapy Laboratory ,Regional Councillor ,Circular Economy ,Lise Alter ,Managing Director ,Senior Executive Vice President Projects ,Nuclear Medicine ,Orano Med ,Alpha Therapy ,Hauts De France ,French General Secretariat ,Prime Minister ,French Agency ,Ecological Transition ,